- Siegel R.L.
- Miller K.D.
- Jemal A.
Cancer statistics, 2019.CA Cancer J. Clin. 2019; 69: 7-34
Incidence of intracranial germ cell tumors by race in the United States, 1992–2010.J. Neuro-Oncol. 2014; 120: 381-388
Germ cell tumours.in: Kurman R.J. WHO Classification of Tumors of Female Reproductive Organs. International Agency for Research on Cancer (IARC),
Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.Endocr. Rev. 2013; 34: 339-376
- Filippou P.
- Ferguson J.E.
- Nielsen M.E.
Epidemiology of prostate and testicular cancer.Semin. Interv. Radiol. 2016; 33: 182-185
Incidence and survival rates for female malignant germ cell tumors.Obstet. Gynecol. 2006; 107: 1075-1085
Age-related biological features of germ cell tumors.Genes Chromosom. Cancer. 2014; 53: 215-227
Ovarian germ cell tumour classification: views from the testis.Histopathology. 2020; 76: 25-36
Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.Mod. Pathol. 2005; 18: S61-S79
- Oosterhuis J.W.
- Looijenga L.H.J.
Human germ cell tumours from a developmental perspective.Nat. Rev. Cancer. 2019; 19: 522-537
Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.J. Clin. Oncol. 2015; 33: 195-201
Validation of the MaGIC pediatric germ cell tumour risk stratification.Eur. Urol. Suppl. 2019; 18: 20
Development of a risk stratification system to guide treatment for female germ cell tumors.Gynecol. Oncol. 2015; 138: 566-572
Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.Int. J. Gynecol. Cancer. 2011; 21: 1414-1421
A multicentre retrospective cohort study of ovarian germ cell tumours: evidence for chemotherapy de-escalation and alignment of paediatric and adult practice.Eur. J. Cancer. 2019; 113: 19-27
Germ cell tumors of the female genital tract.Surg Pathol Clin. 2019; 12: 621-649
Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.Int. J. Gynecol. Cancer. 2014; 24: S48-S54
- Gershenson D.M.
- Frazier A.L.
Conundrums in the management of malignant ovarian germ cell tumors: toward lessening acute morbidity and late effects of treatment.Gynecol. Oncol. 2016; 143: 428-432
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.Ann. Oncol. 2017; 28: 333-338
Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.Br. J. Cancer. 2011; 105: 493-497
Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study—Pediatric Oncology Group 9048 and Children’s Cancer Group 8891.J. Clin. Oncol. 2004; 22: 3563-3569
Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study.J. Pediatr. Surg. 2004; 39 : 424-429
Management of ovarian germ cell tumors.J. Clin. Oncol. 2007; 25: 2938-2943
Fertility-sparing surgery for treatment of non-epithelial ovarian cancer: oncological and reproductive outcomes in a prospective nationwide population-based cohort study.Gynecol. Oncol. 2019; 155: 287-293
Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors.Int. J. Gynecol. Cancer. 2016; 26: 859-864
PVB chemotherapy in patients with recurrent or advanced dysgerminoma: a phase II study of the EORTC Gynaecological Cancer Cooperative Group.Clin Oncol (R Coll Radiol). 1998; 10: 301-305
Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.J. Clin. Oncol. 1991; 9: 1950-1955
Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.Gynecol. Oncol. 2004; 95: 496-499
Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?.Gynecol. Oncol. 2018; 150: 253-260
- Simone C.G.
- Markham M.J.
- Dizon D.S.
Chemotherapy in ovarian germ cell tumors: a systematic review.Gynecol. Oncol. 2016; 141: 602-607
Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.Ann. Intern. Med. 1989; 111: 22-27
Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group.J. Clin. Oncol. 1994; 12: 701-706
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children’s Oncology Group.J. Clin. Oncol. 2014; 32: 465-470
The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity.J. Clin. Oncol. 2000; 18: 3809-3818
Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: a report of the Malignant Germ Cell International Consortium.Eur. J. Cancer. 2018; 98: 30-37
Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials.Pediatr. Blood Cancer. 2013; 60: 587-592
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group/Children’s Cancer Group Intergroup Study.J. Clin. Oncol. 1999; 17: 2137-2143
- Norris H.J.
- Zirkin H.J.
- Benson W.L.
Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases.Cancer. 1976; 37: 2359-2372
Immature teratoma of the ovary.Obstet. Gynecol. 1986; 68: 624-629
Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative.Cancer. 2016; 122: 230-237
Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.Cancer Res. 2010; 70: 2911-2923
Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum.J. Clin. Oncol. 2019; 37: 3090-3098
Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.J. Clin. Oncol. 2009; 27: 4142-4149
Testicular cancer survivorship.J. Natl. Compr. Cancer Netw. 2019; 17: 1557-1568
Increased mortality rates in young and middle-aged patients with malignant germ cell tumours.Br. J. Cancer. 2004; 90: 607-612
Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953–2009).Gynecol. Oncol. 2013; 131: 330-335
Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978–2010).Eur. J. Cancer. 2014; 50: 1942-1950
- Gadducci A.
- Lanfredini N.
- Tana R.
Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours.Gynecol. Endocrinol. 2014; 30: 467-471
Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors.J. Clin. Oncol. 1988; 6: 270-275
Reproductive and sexual function after platinum-based chemotherapy in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group Study.J. Clin. Oncol. 2007; 25: 2792-2797
- de La Motte Rouge T.
- et al.
Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.Ann. Oncol. 2008; 19: 1435-1441
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.J. Clin. Oncol. 2011; 29: 2178-2184
- Reddy Ammakkanavar N.
- et al.
High-dose chemotherapy for recurrent ovarian germ cell tumors.J. Clin. Oncol. 2015; 33: 226-227
High-dose chemotherapy for adult-type ovarian granulosa cell tumors: a retrospective study of the European Society for Blood and Marrow Transplantation.Int. J. Gynecol. Cancer. 2017; 27: 248-251
Phase II study of everolimus in refractory testicular germ cell tumors.Urol. Oncol. 2016; 34
Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group.J. Cancer Res. Clin. Oncol. 2019; 145: 717-723
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.Am. J. Clin. Oncol. 2006; 29: 12-13
Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors.Investig. New Drugs. 2010; 28: 523-528
Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial.Ann. Oncol. 2017; 28: 1346-1351
Brentuximab vedotin in CD30-expressing germ cell tumors after chemotherapy failure.Clin Genitourin Cancer. 2016; 14
Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer Research Network Study GU14-206.Ann. Oncol. 2018; 29: 209-214
An open-label randomized phase 2 study of durvalumab alone or in combination with tremelimumab in patients with advanced germ cell tumors (APACHE): results from the first planned interim analysis.Eur. Urol. 2019; 75: 201-203